New and emerging therapies for bone metastases in genitourinary cancers.
Saylor, Philip J
New and emerging therapies for bone metastases in genitourinary cancers. [electronic resource] - European urology Feb 2013 - 309-20 p. digital
Publication Type: Journal Article; Review
1873-7560
10.1016/j.eururo.2012.10.007 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Bone Density Conservation Agents--therapeutic use
Bone Neoplasms--secondary
Carcinoma--secondary
Denosumab
Diphosphonates--therapeutic use
Female
Humans
Imidazoles--therapeutic use
Kidney Neoplasms--pathology
Male
Prospective Studies
Prostatic Neoplasms--pathology
RANK Ligand--antagonists & inhibitors
Radiopharmaceuticals--therapeutic use
Radium--therapeutic use
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms--pathology
Urogenital Neoplasms--pathology
Urothelium
Zoledronic Acid
New and emerging therapies for bone metastases in genitourinary cancers. [electronic resource] - European urology Feb 2013 - 309-20 p. digital
Publication Type: Journal Article; Review
1873-7560
10.1016/j.eururo.2012.10.007 doi
Antibodies, Monoclonal, Humanized--therapeutic use
Bone Density Conservation Agents--therapeutic use
Bone Neoplasms--secondary
Carcinoma--secondary
Denosumab
Diphosphonates--therapeutic use
Female
Humans
Imidazoles--therapeutic use
Kidney Neoplasms--pathology
Male
Prospective Studies
Prostatic Neoplasms--pathology
RANK Ligand--antagonists & inhibitors
Radiopharmaceuticals--therapeutic use
Radium--therapeutic use
Randomized Controlled Trials as Topic
Urinary Bladder Neoplasms--pathology
Urogenital Neoplasms--pathology
Urothelium
Zoledronic Acid